Citations (33)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (15)
Ambedkar Kumar Yadav, Wenhua Gu, Tongyangzi Zhang, Xianghuai Xu & Li Yu. (2023) Current Perspectives on Biological Therapy for COPD. COPD: Journal of Chronic Obstructive Pulmonary Disease 20:1, pages 197-209.
Read now
Read now
Piotr Damiański, Grzegorz Kardas, Michał Panek, Piotr Kuna & Maciej Kupczyk. (2022) Improving the risk-to-benefit ratio of inhaled corticosteroids through delivery and dose: current progress and future directions. Expert Opinion on Drug Safety 21:4, pages 499-515.
Read now
Read now
Arschang Valipour, Zaurbek Aisanov, Sergey Avdeev, Vladimir Koblizek, Ivan Kocan, Ivan Kopitovic, Gergely Lupkovics, Milena Man, Maris Bukovskis, Neven Tudoric, Marija Vukoja, Wojciech Naumnik & Nikolay Yanev. (2022) Recommendations for COPD management in Central and Eastern Europe. Expert Review of Respiratory Medicine 16:2, pages 221-234.
Read now
Read now
Jae-Hwa Choi, Keun-Bae Jeong, You Hyun Park, Iseul Yu, Seok Jeong Lee, Myoung Kyu Lee, Sang-Ha Kim, Won-Yeon Lee, Suk Joong Yong & Ji-Ho Lee. (2021) Comparison of Risk of Pneumonia Caused by Fluticasone Propionate versus Budesonide in Chronic Obstructive Pulmonary Disease: A Nationwide Retrospective Cohort Study. International Journal of Chronic Obstructive Pulmonary Disease 16, pages 3229-3237.
Read now
Read now
Ronald F. Grossman. (2021) Blood eosinophils in COPD to predict exacerbations and inform inhaled corticosteroid use: Need for further evidence?. Canadian Journal of Respiratory, Critical Care, and Sleep Medicine 5:3, pages 136-149.
Read now
Read now
Maria Gabriella Matera, Josuel Ora, Luigino Calzetta, Paola Rogliani & Mario Cazzola. (2021) Sex differences in COPD management. Expert Review of Clinical Pharmacology 14:3, pages 323-332.
Read now
Read now
Andriana I Papaioannou, Stelios Loukides, Petros Bakakos, Epameinondas N Kosmas, Nikoletta Rovina, Paschalis Steiropoulos, Evangellia Fouka, Georgios Hillas, Georgios Patentalakis, Marousa Kouvela & Nikos Tzanakis. (2020) Dual Bronchodilator in the Era of Triple Therapy. International Journal of Chronic Obstructive Pulmonary Disease 15, pages 2695-2705.
Read now
Read now
G. Hillas, A. Papaporfyriou, K. Dimakou & A. I. Papaioannou. (2020) Pharmacological treatment of stable COPD: need for a simplified approach. Postgraduate Medicine 132:2, pages 126-131.
Read now
Read now
Jørgen Vestbo, Claus F Vogelmeier, Mark Small, James Siddall, Robert Fogel & Konstantinos Kostikas. (2019) Inhaled corticosteroid use by exacerbations and eosinophils: a real-world COPD population. International Journal of Chronic Obstructive Pulmonary Disease 14, pages 853-861.
Read now
Read now
Maria Gabriella Matera, Luigino Calzetta, Ermanno Puxeddu, Paola Rogliani & Mario Cazzola. (2018) A safety comparison of LABA+LAMA vs LABA+ICS combination therapy for COPD. Expert Opinion on Drug Safety 17:5, pages 509-517.
Read now
Read now
Paola Rogliani, Luigino Calzetta, Mario Cazzola & Maria Gabriella Matera. (2016) Drug safety evaluation of roflumilast for the treatment of COPD: a meta-analysis. Expert Opinion on Drug Safety 15:8, pages 1133-1146.
Read now
Read now
Pavlina A. Andreeva-Gateva, Eleonora Stamenova & Tzvetelin Gatev. (2016) The place of inhaled corticosteroids in the treatment of chronic obstructive pulmonary disease: a narrative review. Postgraduate Medicine 128:5, pages 474-484.
Read now
Read now
Mario Cazzola, Paola Rogliani, Josuel Ora & Maria Gabriella Matera. (2016) Treatment options for moderate-to-very severe chronic obstructive pulmonary disease. Expert Opinion on Pharmacotherapy 17:7, pages 977-988.
Read now
Read now
Cheng-Yi Wang, Chih-Cheng Lai, Wei-Chih Yang, Chia-Chieh Lin, Likwang Chen, Hao-Chien Wang & Chong-Jen Yu. (2016) The association between inhaled corticosteroid and pneumonia in COPD patients: the improvement of patients’ life quality with COPD in Taiwan (IMPACT) study. International Journal of Chronic Obstructive Pulmonary Disease 11, pages 2775-2783.
Read now
Read now
Ian A. Yang, Janet G. Shaw, John R. Goddard, Melissa S. Clarke & David W. Reid. (2016) Use of inhaled corticosteroids in COPD: improving efficacy. Expert Review of Respiratory Medicine 10:3, pages 339-350.
Read now
Read now
Articles from other publishers (18)
Jennifer K. Quint, Amnon Ariel & Peter J. Barnes. (2023) Rational use of inhaled corticosteroids for the treatment of COPD. npj Primary Care Respiratory Medicine 33:1.
Crossref
Crossref
Pradeesh Sivapalan & Jens-Ulrik Jensen. (2022) Biomarker bei chronisch-obstruktiven Lungenerkrankungen: Zunehmende Rolle von Eosinophilen und Procalcitonin. Kompass Pneumologie 10:2, pages 52-59.
Crossref
Crossref
Pradeesh Sivapalan & Jens-Ulrik Jensen. (2022) Biomarkers in Chronic Obstructive Pulmonary Disease: Emerging Roles of Eosinophils and Procalcitonin. Journal of Innate Immunity 14:2, pages 89-97.
Crossref
Crossref
Alexander Jordan, Pradeesh Sivapalan, Josefin Eklöf, Jakob B. Vestergaard, Howraman Meteran, Mohamad Isam Saeed, Tor Biering-Sørensen, Anders Løkke, Niels Seersholm & Jens Ulrik Stæhr Jensen. (2021) The Association between Use of ICS and Psychiatric Symptoms in Patients with COPD—A Nationwide Cohort Study of 49,500 Patients. Biomedicines 9:10, pages 1492.
Crossref
Crossref
Suyun Yu, Caili Zhang, Zhijun Yan, Qingqing Fang & Xiwen Gao. (2021) Tiotropium Bromide Attenuates Mucus Hypersecretion in Patients with Stable Chronic Obstructive Pulmonary Disease. Computational and Mathematical Methods in Medicine 2021, pages 1-6.
Crossref
Crossref
Ruohan Yang, Guiqing Liu & Chaosheng Deng. (2021) Pulmonary embolism with chronic obstructive pulmonary disease. Chronic Diseases and Translational Medicine 7:3, pages 149-156.
Crossref
Crossref
Maria Gabriella Matera, Mario Cazzola & Clive Page. (2021) Prospects for COPD treatment. Current Opinion in Pharmacology 56, pages 74-84.
Crossref
Crossref
Alessandro Celi, Manuela Latorre, Pierluigi Paggiaro & Riccardo Pistelli. (2021) Chronic obstructive pulmonary disease: moving from symptom relief to mortality reduction. Therapeutic Advances in Chronic Disease 12, pages 204062232110140.
Crossref
Crossref
Mohamed E. A. Abdelrahim, Haitham Saeed, Hadeer S. Harb & Yasmin M. MadneyMohamed E. A. Abdelrahim, Haitham Saeed, Hadeer S. Harb & Yasmin M. Madney. 2021. Essentials of Aerosol Therapy in Critically ill Patients. Essentials of Aerosol Therapy in Critically ill Patients
137
149
.
Tanja Fens, Simon van der Pol, Janwillem W.H. Kocks, Maarten J. Postma & Job F.M. van Boven. (2019) Economic Impact of Reducing Inappropriate Inhaled Corticosteroids Use in Patients With Chronic Obstructive Pulmonary Disease: ISPOR's Guidance on Budget Impact in Practice. Value in Health 22:10, pages 1092-1101.
Crossref
Crossref
Shinichiro Okauchi, Kensuke Kinoshita, Shinya Sato, Hajime Osawa, Hideyasu Yamada, Kunihiko Miyazaki, Hiroaki Satoh, Nobuyuki Hizawa & Hiroyuki Kobayashi. (2019) Rinsing of oropharynx and storage place of respiratory medicine inhaler: A cross‐sectional audit. Journal of General and Family Medicine 20:3, pages 101-106.
Crossref
Crossref
I. V. Leshchenko. (2018) Possibilities and limitations of inhaled corticosteroids in the treatment of chronic obstructive pulmonary disease. Russian Pulmonology 28:5, pages 602-612.
Crossref
Crossref
Mario Cazzola & Clive Page. (2018) An inhaled “bifunctional” dual PDE3/4 inhibitor provides additional short-term improvements in lung function compared to existing classes of bronchodilator: implications for future treatment of COPD. European Respiratory Journal 52:5, pages 1801675.
Crossref
Crossref
Guy Brusselle, Ian D. Pavord, Sarah Landis, Steven Pascoe, Sally Lettis, Nikhil Morjaria, Neil Barnes & Emma Hilton. (2018) Blood eosinophil levels as a biomarker in COPD. Respiratory Medicine 138, pages 21-31.
Crossref
Crossref
Janis K. Shute, Luigino Calzetta, Vittorio Cardaci, Stefania di Toro, Clive P. Page & Mario Cazzola. (2018) Inhaled nebulised unfractionated heparin improves lung function in moderate to very severe COPD: A pilot study. Pulmonary Pharmacology & Therapeutics 48, pages 88-96.
Crossref
Crossref
Mario Cazzola & Paola Rogliani. (2017)
In stable COPD, long-acting muscarinic antagonist plus long-acting beta-agonists resulted in less exacerbations, pneumonia and larger improvement in FEV
1
than long-acting beta-agonists plus inhaled corticosteroids
. Evidence Based Medicine 22:5, pages 183-184.
Crossref
Crossref
Dave Singh, Massimo Corradi, Monica Spinola, Stefano Petruzzelli & Alberto Papi. (2016) Extrafine beclometasone diproprionate/formoterol fumarate: a review of its effects in chronic obstructive pulmonary disease. npj Primary Care Respiratory Medicine 26:1.
Crossref
Crossref
Paola Rogliani, Gabriella Lucà & Davide Lauro. (2015) Chronic obstructive pulmonary disease and diabetes. COPD Research and Practice 1:1.
Crossref
Crossref